- Home
- EMD vs MLAB Comparison
EMD vs MLAB Comparison
Compare EMD & MLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | EMD | MLAB |
|---|---|---|
| Founded | 2003 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Industrial Machinery/Components |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 609.8M | 719.9M |
| IPO Year | 2003 | 1995 |
Fundamental Metrics
Financial Performance| Metric | EMD | MLAB |
|---|---|---|
| Price | $9.20 | $140.12 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 288.8K | 85.1K |
| Earning Date | 01-01-0001 | 11-09-2026 |
| Dividend Yield | ★ 10.25% | 0.47% |
| EPS Growth | N/A | ★ 436.11 |
| EPS | N/A | ★ 1.25 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $2.30 |
| Revenue Next Year | N/A | $4.41 |
| P/E Ratio | ★ N/A | $108.67 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.05 | $69.51 |
| 52 Week High | $11.30 | $144.35 |
Technical Indicators
Market Signals| Indicator | EMD | MLAB |
|---|---|---|
| Relative Strength Index (RSI) | 43.01 | 61.27 |
| Support Level | $9.08 | $119.77 |
| Resistance Level | $9.52 | $144.35 |
| Average True Range (ATR) | 0.14 | 6.27 |
| MACD | 0.00 | 1.42 |
| Stochastic Oscillator | 23.16 | 87.63 |
Price Performance
Historical ComparisonAbout EMD Western Asset Emerging Markets Debt Fund Inc
Western Asset Emg Markets Debt Fund Inc is a non-diversified closed-end management and long term investment company. The primary investment objective of the company is to seek high current income, and the secondary objective is to seek capital appreciation.
About MLAB Mesa Laboratories Inc.
Mesa Laboratories Inc manufactures life sciences tools and critical quality control solutions. It operates in four divisions: i) Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. ii) Clinical Genomics division develops, manufactures, and sells sensitive, low-cost, high-throughput genetic analysis tools and related consumables. iii) The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. iv) The Calibration Solutions division develops, manufactures, sells, and services quality control products.